Literature DB >> 26562228

Predicting prosthetic prescription after major lower-limb amputation.

Linda Resnik1, Matthew Borgia.   

Abstract

We describe prosthetic limb prescription in the first year following lower-limb amputation and examine the relationship between amputation level, geographic region, and prosthetic prescription. We analyzed 2005 to 2010 Department of Veterans Affairs (VA) Inpatient and Medical Encounters SAS data sets, Vital Status death data, and National Prosthetic Patient Database data for 9,994 Veterans who underwent lower-limb amputation at a VA hospital. Descriptive statistics and bivariates were examined. Cox proportional hazard models identified factors associated with prosthetic prescription. Analyses showed that amputation level was associated with prosthetic prescription. The hazard ratios (HRs) were 1.41 for ankle amputation and 0.46 for transfemoral amputation compared with transtibial amputation. HRs for geographic region were Northeast = 1.49, Upper Midwest = 1.26, and West = 1.39 compared with the South (p < 0.001). African American race, longer length of hospital stay, older age, congestive heart failure, paralysis, other neurological disease, renal failure, and admission from a nursing facility were negatively associated with prosthetic prescription. Being married was positively associated. After adjusting for patient characteristics, people with ankle amputation were most likely to be prescribed a prosthesis and people with transfemoral amputation were least likely. Geographic variation in prosthetic prescription exists in the VA and further research is needed to explain why.

Entities:  

Keywords:  Veteran; amputation; amputee; assistive technology; limb loss; lower limb; prescription; prosthetics; regional variation; rehabilitation

Mesh:

Year:  2015        PMID: 26562228     DOI: 10.1682/JRRD.2014.09.0216

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  7 in total

1.  Male sex, Gustillo-Anderson type III open fracture and definitive external fixation are risk factors for a return to the or following the surgical management of geriatric low energy open ankle fractures.

Authors:  Mitchell S Fourman; Joshua Adjei; Richard Wawrose; Gele Moloney; Peter A Siska; Ivan S Tarkin
Journal:  Injury       Date:  2021-11-12       Impact factor: 2.586

2.  Osseointegrated total hip replacement connected to a lower limb prosthesis: a proof-of-concept study with three cases.

Authors:  Aditya Khemka; Chalak I FarajAllah; Sarah J Lord; Belinda Bosley; Munjed Al Muderis
Journal:  J Orthop Surg Res       Date:  2016-01-19       Impact factor: 2.359

3.  SwedeAmp-the Swedish Amputation and Prosthetics Registry: 8-year data on 5762 patients with lower limb amputation show sex differences in amputation level and in patient-reported outcome.

Authors:  Ilka Kamrad; Bengt Söderberg; Hedvig Örneholm; Kerstin Hagberg
Journal:  Acta Orthop       Date:  2020-04-22       Impact factor: 3.717

4.  A Prospective Assessment of an Adjustable, Immediate Fit, Subischial Transfemoral Prosthesis.

Authors:  Timothy R Dillingham; Jessica L Kenia; Frances S Shofer; James S Marschalek
Journal:  Arch Rehabil Res Clin Transl       Date:  2022-05-02

5.  Financial difficulty in community-dwelling persons with lower limb loss is associated with reduced self-perceived health and wellbeing.

Authors:  Szu-Ping Lee; Lung-Chang Chien; Tyler Chin; Heather Fox; Juan Gutierrez
Journal:  Prosthet Orthot Int       Date:  2020-06-02       Impact factor: 1.895

6.  Suitability of 'Guidelines for Screening of Prosthetic Candidates: Lower Limb' for the Eastern Cape, South Africa: A qualitative study.

Authors:  Luphiwo L Mduzana; Surona Visagie; Gubela Mji
Journal:  S Afr J Physiother       Date:  2018-01-30

7.  Cost-effectiveness and budget impact of the microprocessor-controlled knee C-Leg in transfemoral amputees with and without diabetes mellitus.

Authors:  Alexander Kuhlmann; Henning Krüger; Susanne Seidinger; Andreas Hahn
Journal:  Eur J Health Econ       Date:  2020-01-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.